Table 2.
Patients | Prednisolone (mg/day) | MTX (mg/week) | Other |
---|---|---|---|
Pre-RTX | |||
1 | 0 | 12.5 | |
2 | 5 | 25 | |
3 | 7.5 | 20 | |
4 | 6.25 | 10 | |
5 | 10 | 20 | |
Post-RTX | |||
1 | 5 | 20 | |
2 | 0 | 20 | Cyclosporin A |
3 | 0 | 25 | |
4 | 0 | 15 | |
5 | 5 | 10 | |
6 | 5 | 25 | |
7 | 0 | 2.5 | Azathioprine |
8 | 0 | 10 | |
9 | 2.5 | 22.5 | Cyclosporin A |
10 | 0 | 20 | |
11 | 5 | 10 | |
Controls | |||
1 | 0 | 15 | Sulfasalazine |
2 | 5 | 10 | |
3 | 0 | 25 | Sulfasalazine |
4 | 0 | 10 | Hydroxychlorokin + cyclosporin A |
5 | 0 | 20 | Hydroxychlorokin |
6 | 0 | 20 | Etanercept |
7 | 0 | 20 | |
8 | 0 | 25 | Hydroxychlorokin |
9 | 0 | 20 | Infliximab |
10 | 0 | 20 |
MTX, methotrexate; RTX, rituximab.